Cardio Diagnostics-CW26CDIOWPreferred / convertible
13F holders, Q1 2025 (March 31)7holders +1
1new positions
0sold out
1famous investor
$0.07avg. 13F price*
At the end of Q1 2025, 7 institutions reported holding Cardio Diagnostics-CW26 (CDIOW) in their 13F filings, up 1 from Q4 2024. 1 opened new positions and 0 sold out. The largest holders were Boothbay Fund Management, LLC ($20K), Saba Capital Management, L.P. ($7K) and D. E. Shaw & Co. ($4K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Cardio Diagnostics-CW26
- CUSIP
- 14159C111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $46 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 1,151 shares bought and 200 shares sold, net +951 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Boothbay Fund Management, LLC | — | No change | 60,540 | $20K |
| Saba Capital Management, L.P. | — | No change | 199,839 | $7K |
| D. E. Shaw & Co. | — | No change | 74,822 | $4K |
| Clear Street LLC | — | Reduce -0.2% | 82,642 | $3K |
| Context Capital Management, LLC | — | No change | 81,500 | $3K |
| Atw Spac Management LLC | — | No change | 60,540 | $2K |
| UBS Group AG | — | New | 1,151 | $46 |
"% of holder's portfolio" is CDIOW's weight in each manager's 13F, not the share of Cardio Diagnostics-CW26 the manager owns.